Literature DB >> 32557799

The importance of the ZBED6-IGF2 axis for metabolic regulation in mouse myoblast cells.

Shady Younis1, Rakan Naboulsi1, Xuan Wang2, Xiaofang Cao1, Mårten Larsson1, Ernest Sargsyan2, Peter Bergsten2, Nils Welsh2, Leif Andersson1,3,4.   

Abstract

The transcription factor ZBED6 acts as a repressor of Igf2 and affects directly or indirectly the transcriptional regulation of thousands of genes. Here, we use gene editing in mouse C2C12 myoblasts and show that ZBED6 regulates Igf2 exclusively through its binding site 5'-GGCTCG-3' in intron 1 of Igf2. Deletion of this motif (Igf2ΔGGCT ) or complete ablation of Zbed6 leads to ~20-fold upregulation of the IGF2 protein. Quantitative proteomics revealed an activation of Ras signaling pathway in both Zbed6-/- and Igf2ΔGGCT myoblasts, and a significant enrichment of mitochondrial membrane proteins among proteins showing altered expression in Zbed6-/- myoblasts. Both Zbed6-/- and Igf2ΔGGCT myoblasts showed a faster growth rate and developed myotube hypertrophy. These cells exhibited an increased O2 consumption rate, due to IGF2 upregulation. Transcriptome analysis revealed ~30% overlap between differentially expressed genes in Zbed6-/- and Igf2ΔGGCT myotubes, with an enrichment of upregulated genes involved in muscle development. In contrast, ZBED6-overexpression in myoblasts led to cell apoptosis, cell cycle arrest, reduced mitochondrial activities, and ceased myoblast differentiation. The similarities in growth and differentiation phenotypes observed in Zbed6-/- and Igf2ΔGGCT myoblasts demonstrates that ZBED6 affects mitochondrial activity and myogenesis largely through its regulation of IGF2 expression. This study adds new insights how the ZBED6-Igf2 axis affects muscle metabolism.
© 2020 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  IGF2; ZBED6; mitochondria; myogenesis and gene editing

Year:  2020        PMID: 32557799     DOI: 10.1096/fj.201901321R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

1.  [Dihydromyricetin reverses Herceptin resistance by up-regulating miR-98-5p and inhibiting IGF1R/HER2 dimer formation in SKBR3 cells].

Authors:  M Zhang; C Guo; Y Chu; R Xu; F Yin; J Qian
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-02-20

2.  Liver Expression of IGF2 and Related Proteins in ZBED6 Gene-Edited Pig by RNA-Seq.

Authors:  Haidong Zhao; Mingli Wu; Shirong Liu; Xiaoqin Tang; Xiaohua Yi; Qi Li; Shuhui Wang; Xiuzhu Sun
Journal:  Animals (Basel)       Date:  2020-11-22       Impact factor: 2.752

3.  ZBED6 regulates Igf2 expression partially through its regulation of miR483 expression.

Authors:  Rakan Naboulsi; Mårten Larsson; Leif Andersson; Shady Younis
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

4.  Efficient Editing of the ZBED6-Binding Site in Intron 3 of IGF2 in a Bovine Model Using the CRISPR/Cas9 System.

Authors:  Huiying Zou; Dawei Yu; Shun Yao; Fangrong Ding; Junliang Li; Ling Li; Xue Li; Shanjiang Zhao; Yunwei Pang; Haisheng Hao; Weihua Du; Xueming Zhao; Yunping Dai; Huabin Zhu
Journal:  Genes (Basel)       Date:  2022-06-24       Impact factor: 4.141

5.  Knockdown of insulin-like growth factor 2 gene disrupts mitochondrial functions in the liver.

Authors:  Weiwei Gui; Yiyi Zhu; Shuiya Sun; WeiFen Zhu; Bowen Tan; Hanxin Zhao; Chengxin Shang; Fenping Zheng; Xihua Lin; Hong Li
Journal:  J Mol Cell Biol       Date:  2021-05-14       Impact factor: 6.216

6.  ZBED6 counteracts high-fat diet-induced glucose intolerance by maintaining beta cell area and reducing excess mitochondrial activation.

Authors:  Xuan Wang; Shady Younis; Jing Cen; Yun Wang; Camilla Krizhanovskii; Leif Andersson; Nils Welsh
Journal:  Diabetologia       Date:  2021-07-22       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.